1 | Laboratory experiments before and after mepolizumab treatment (D04923) | - | - | - | - | [2] 44 44, 45 💬
|
2 | Mepolizumab (D04923) | [1] Mepolizumab Mepolizumab | [1] Mepolizumab
Mepolizumab
(D04923) 💬
| [1] IL5 IL5 💬
| [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [4] 44 44, 45, 98, 162 💬
|
3 | Mepolizumab 100 MG (D04923) | [1] Mepolizumab Mepolizumab | [1] Mepolizumab
Mepolizumab
(D04923) 💬
| [1] IL5 IL5 💬
| [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [1] 98 98 💬
|
4 | Mepolizumab 300 MG (D04923) | [1] Mepolizumab Mepolizumab | [1] Mepolizumab
Mepolizumab
(D04923) 💬
| [1] IL5 IL5 💬
| [13] Allograft rejection Allograft rejection, Asthma, Autoimmune thyroid disease, Cytokine-cytokine receptor interaction, Fc epsilon RI signaling pathway, Hematopoietic cell lineage, IL-17 signaling pathway, Inflammatory bowel disease, Intestinal immune network for IgA production, JAK-STAT signaling pathway, Pathways in cancer, T cell receptor signaling pathway, Th1 and Th2 cell differentiation 💬 | [1] 98 98 💬
|